Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 32

Trial Status

Completed1
Recruiting1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT07441681Phase 3Recruiting
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin
Locally Advanced Hypopharyngeal Squamous Cell CarcinomaLocally Advanced Laryngeal Squamous Cell CarcinomaLocally Advanced Oral Cavity Squamous Cell Carcinoma+1 more
PrincipalinvestigatorStart date: 2026-07-31
NCT03258554Phase 2/3Completed
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Head and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma+17 more
PrincipalinvestigatorStart date: 2018-04-03

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Charalampos Floudas, M.D.

National Cancer Institute (NCI)

Related
9 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckOral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Renata Ferrarotto

M.D. Anderson Cancer Center

Related
7 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the LarynxStage III Laryngeal Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Nina Bhardwaj, MD, PhD

Icahn School of Medicine at Mount Sinai

Related
8 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Dan Zandberg, MD

UPMC Hillman Cancer Center

Related
6 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score1%

Ezra Cohen, MD

University of Chicago

Related
6 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score1%

Ari Rosenberg, MD

University of Chicago

Related
5 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score1%

Jared Weiss, MD

University of North Carolina, Chapel Hill

Related
7 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score1%

chunmei Bai

Peking Union Medical College Hospital

Related
4 trials

Shared therapeutic areas:

Hypopharyngeal Squamous Cell Carcinoma
Similarity Score1%

Anna Spreafico, MD

Princess Margaret Cancer Centre

Related
6 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT07441681Phase 3PrincipalInvestigator

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin

Locally Advanced Hypopharyngeal Squamous Cell CarcinomaLocally Advanced Laryngeal Squamous Cell CarcinomaLocally Advanced Oral Cavity Squamous Cell Carcinoma+1 more
Recruiting
NCT03258554Phase 2/3PrincipalInvestigator

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Head and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma+17 more
Completed

All 2 trials loaded